Walnut Creek, CALIFORNIA4 Active Studies

Urticaria Clinical Trials in Walnut Creek, CALIFORNIA

Find 4 actively recruiting urticaria clinical trials in Walnut Creek, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
476
Enrolling

Recruiting Urticaria Studies in Walnut Creek

RecruitingWalnut Creek, CALIFORNIANCT06842823

A Study of Navenibart in Participants With Hereditary Angioedema

This is a Phase 3 multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of subcutaneous administration of navenibart in adult and adolescent parti...

145 participants
Astria Therapeutics, Inc.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06679881

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angio...

130 participants
Pharvaris Netherlands B.V.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06343779

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, 2-period, 2-treatment cross-over study to evaluate the efficacy and safety of orally administered deucrictibant compared t...

120 participants
Pharvaris Netherlands B.V.
View Study Details
RecruitingWalnut Creek, CALIFORNIANCT06669754

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared ...

81 participants
Pharvaris Netherlands B.V.
View Study Details

About Urticaria Clinical Trials in Walnut Creek

Urticaria (hives) presents as raised, itchy welts on the skin triggered by allergens, medications, infections, or other factors. Acute urticaria resolves within six weeks, while chronic forms persist longer. Treatment includes antihistamines, corticosteroids for severe episodes, and biologics for chronic cases.

There are currently 4 urticaria clinical trials recruiting participants in Walnut Creek, CALIFORNIA. These studies are seeking a combined 476 participants. Research is being sponsored by Astria Therapeutics, Inc., Pharvaris Netherlands B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Urticaria Clinical Trials in Walnut Creek — FAQ

Are there urticaria clinical trials in Walnut Creek?

Yes, there are 4 urticaria clinical trials currently recruiting in Walnut Creek, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Walnut Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.

Are clinical trials in Walnut Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.

What urticaria treatments are being tested?

The 4 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for urticaria.

Data updated March 2, 2026 from ClinicalTrials.gov